Exelixis (EXEL) Current Deferred Revenue: 2010-2023
Historic Current Deferred Revenue for Exelixis (EXEL) over the last 10 years, with Jun 2023 value amounting to $13.5 million.
- Exelixis' Current Deferred Revenue fell 8.13% to $13.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $13.5 million, marking a year-over-year decrease of 8.13%. This contributed to the annual value of $14.1 million for FY2022, which is 15.00% down from last year.
- According to the latest figures from Q2 2023, Exelixis' Current Deferred Revenue is $13.5 million, which was up 1.21% from $13.4 million recorded in Q1 2023.
- Exelixis' Current Deferred Revenue's 5-year high stood at $19.0 million during Q2 2021, with a 5-year trough of $321,000 in Q2 2019.
- For the 3-year period, Exelixis' Current Deferred Revenue averaged around $14.3 million, with its median value being $14.7 million (2022).
- Over the last 5 years, Exelixis' Current Deferred Revenue had its largest YoY gain of 4,977.88% in 2020, and its largest YoY loss of 96.39% in 2020.
- Exelixis' Current Deferred Revenue (Quarterly) stood at $8.2 million in 2019, then rose by 29.27% to $10.6 million in 2020, then spiked by 198.52% to $16.6 million in 2021, then fell by 15.00% to $14.1 million in 2022, then declined by 8.13% to $13.5 million in 2023.
- Its Current Deferred Revenue was $13.5 million in Q2 2023, compared to $13.4 million in Q1 2023 and $14.1 million in Q4 2022.